Independent studies bring to the findings that PYCR1 is overexpressed also in non-small cell lung cancer (NSCLC) and has been associated with poor prognosis in patients with NSCLC (37–40). The gene discussed is PYCR1; the disease is non-small cell lung carcinoma.